Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 0.90%176.52M | -89.62%4.38M | 169.19%350.72M | 102.37%125.1M | -33.11%8.43M | 115.65%174.95M | 267.34%42.25M | -40.65%130.29M | -29.61%61.82M | 126.14%12.6M |
Net income from continuing operations | 2.26%61.62M | -371.04%-12.38M | 195.74%177.81M | 331.64%118.17M | 89.60%-5.18M | 143.49%60.25M | 118.47%4.57M | -267.24%-185.72M | 185.90%27.38M | 28.73%-49.81M |
Operating gains losses | -1,559.79%-29.35M | 234.08%7.71M | -127.88%-4.36M | 115.50%1.53M | -64.95%1.62M | -104.95%-1.77M | 61.09%-5.75M | 139.23%15.64M | -18.06%-9.9M | 313.72%4.63M |
Depreciation and amortization | -9.92%35.21M | -11.01%35.55M | -6.57%151.76M | -12.73%35.66M | -6.74%37.07M | -4.37%39.09M | -2.44%39.94M | -7.54%162.43M | -3.37%40.86M | -8.93%39.75M |
Deferred tax | 142.33%422K | 363.95%2.95M | -182.19%-94.44M | -8,809.70%-95.51M | 437.75%3.19M | -100.85%-997K | -9.18%-1.12M | 402.26%114.91M | 71.47%-1.07M | -104.16%-943K |
Other non cash items | 344.88%2.04M | 208.06%1.33M | -87.80%1.62M | 154.55%1.07M | -60.12%1.31M | -95.29%459K | -156.95%-1.23M | 196.58%13.24M | 64.27%-1.97M | 150.61%3.29M |
Change In working capital | 53.01%92.2M | -601.39%-46.4M | 239.03%52.75M | 579.91%47.09M | -790.36%-47.98M | 1,691.85%60.26M | 82.79%-6.62M | -150.35%-37.94M | -112.04%-9.81M | 114.29%6.95M |
-Change in receivables | 180.55%13.27M | -251.97%-7.78M | 103.79%161K | 1,003.85%6.59M | -1,532.00%-8.95M | 18.40%4.73M | 76.65%-2.21M | 76.58%-4.24M | 268.17%597K | 113.41%625K |
-Change in inventory | -34.38%3.75M | -2,470.82%-10.31M | 3.75%11.78M | -65.78%4.77M | -92.83%1.7M | -43.94%5.71M | 98.90%-401K | 125.75%11.35M | 215.03%13.95M | 373.87%23.65M |
-Change in prepaid assets | -204.29%-10.14M | -181.40%-3.43M | 780.09%15.56M | 54.99%10.6M | -49.67%4.08M | 79.59%-3.33M | 33.74%4.21M | 129.52%1.77M | -46.52%6.84M | 192.03%8.11M |
-Change in payables and accrued expense | 60.53%85.33M | -202.75%-24.88M | 153.94%25.26M | 180.55%25.13M | -76.17%-44.81M | 864.66%53.15M | -291.18%-8.22M | -132.62%-46.82M | -138.42%-31.2M | 4.17%-25.43M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 0.90%176.52M | -89.62%4.38M | 169.19%350.72M | 102.37%125.1M | -33.11%8.43M | 115.65%174.95M | 267.34%42.25M | -40.65%130.29M | -29.61%61.82M | 126.14%12.6M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -91.93%-37.56M | -135.56%-25.5M | 47.35%-54.61M | -314.12%-9.91M | -703.25%-14.31M | -254.13%-19.57M | 89.29%-10.83M | -2,495.07%-103.73M | -89.63%4.63M | -106.22%-1.78M |
Capital expenditure reported | -19.57%-16.68M | -1.21%-14.57M | -0.90%-58.31M | -9.72%-14.93M | -0.67%-15.04M | -0.22%-13.95M | 6.09%-14.4M | 11.50%-57.79M | 11.78%-13.61M | 15.82%-14.94M |
Net PPE purchase and sale | -131.94%-26.42M | 24.66%-17M | -2.15%-54.93M | 35.52%-10.5M | 4.78%-10.47M | 22.69%-11.39M | -91.91%-22.57M | 0.50%-53.77M | -36.88%-16.29M | 29.53%-11M |
Net business purchase and sale | ---- | ---- | 21.76%-3.62M | ---3.62M | ---- | ---- | ---- | 93.85%-4.63M | --0 | 34.57%-4.13M |
Net investment purchase and sale | 0.41%5.44M | -78.05%4.5M | 378.66%38.68M | -93.75%2M | -61.27%10.76M | -75.80%5.42M | 127.67%20.5M | -94.73%8.08M | -48.09%32M | -58.34%27.78M |
Net other investing changes | -72.16%98K | -72.14%1.57M | 437.77%23.57M | 580.94%17.15M | -13.63%431K | -71.68%352K | 4,519.67%5.64M | -88.21%4.38M | -75.57%2.52M | -69.41%499K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -91.93%-37.56M | -135.56%-25.5M | 47.35%-54.61M | -314.12%-9.91M | -703.25%-14.31M | -254.13%-19.57M | 89.29%-10.83M | -2,495.07%-103.73M | -89.63%4.63M | -106.22%-1.78M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -385.19%-58.66M | -1.00%-35.42M | -25.66%-222.55M | -26.70%-65.05M | -745.54%-110.35M | 88.02%-12.09M | -197.67%-35.07M | -66.18%-177.11M | -556.02%-51.34M | 73.58%-13.05M |
Net issuance payments of debt | 44.96%-5.68M | 86.33%-3.58M | 26.79%-48.56M | 88.76%-5.69M | -31.20%-6.36M | -99.00%-10.31M | -362.14%-26.19M | -27.50%-66.33M | -776.86%-50.63M | 11.33%-4.85M |
Net common stock issuance | -700,066.67%-42M | -11,831.71%-9.62M | -47,463.91%-154.88M | -16,896.94%-54.93M | ---100.04M | --6K | --82K | --327K | --327K | --0 |
Net other financing activities | -515.81%-10.99M | -148.12%-22.21M | 82.80%-19.11M | -327.29%-4.43M | 51.88%-3.95M | 98.14%-1.78M | -46.48%-8.95M | -103.67%-111.1M | 49.46%-1.04M | 81.33%-8.2M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -385.19%-58.66M | -1.00%-35.42M | -25.66%-222.55M | -26.70%-65.05M | -745.54%-110.35M | 88.02%-12.09M | -197.67%-35.07M | -66.18%-177.11M | -556.02%-51.34M | 73.58%-13.05M |
Net cash flow | ||||||||||
Beginning cash position | 22.17%152.95M | 56.37%203.78M | -52.96%130.31M | 34.22%154.34M | 146.41%274.21M | -5.22%125.2M | -52.96%130.31M | 51.38%277.05M | -28.80%114.99M | -51.86%111.28M |
Current changes in cash | -43.96%80.3M | -1,454.41%-56.53M | 148.86%73.56M | 232.06%50.14M | -5,103.13%-116.24M | 665.57%143.29M | 97.37%-3.64M | -238.15%-150.54M | -87.88%15.1M | 96.76%-2.23M |
Effect of exchange rate changes | -254.18%-8.82M | 486.59%5.71M | -102.47%-94K | -418.47%-707K | -300.11%-3.63M | -33.80%5.72M | 78.53%-1.48M | 125.45%3.8M | 102.44%222K | 353.14%1.82M |
End cash Position | -18.15%224.43M | 22.17%152.95M | 56.37%203.78M | 56.37%203.78M | 34.22%154.34M | 146.41%274.21M | -5.22%125.2M | -52.96%130.31M | -52.96%130.31M | -28.80%114.99M |
Free cash flow | -10.82%133.42M | -613.76%-27.19M | 1,167.96%237.49M | 212.20%99.67M | -28.10%-17.08M | 185.09%149.61M | 110.11%5.29M | -81.31%18.73M | -47.23%31.92M | 83.65%-13.33M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |